Alfa Marushima Tokyo Japan

alfa-marushima-tokyo-japan

Wall Street’s Next Obsession? Alzheimer’s Drugs Could Rival Weight Loss Boom

 Alzheimer’s disease affects millions globally, with cases expected to double by 2060 to nearly 14 million adults against the backdrop of minimal treatment options  In clinical trials today, Tiziana Life Sciences’ intranasal Foralumab shows promise in addressing neuroinflammation associated with Alzheimer’s Doctors and Brigham & Women’s Hospital are eager to expand indications and the number […]